Literature DB >> 31499423

Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone).

Sabrina Lehmann1, Andreas Thomas2, Karl-Heinz Schiwy-Bochat1, Hans Geyer2, Mario Thevis2, Frank Glenewinkel1, Markus Alexander Rothschild1, Hilke Andresen-Streichert1, Martin Juebner3.   

Abstract

A 34-year old male was found breathless and panting at home by his girlfriend three hours after a gym workout. Minutes later, he collapsed and died. Autopsy, histological and chemical analyses were conducted. The examination of the heart showed left ventricular hypertrophy, while the right coronary artery showed only a small vascular lumen (3 mm in diameter), due to its anatomical structure. In femoral blood concentrations of approx. 1 μg/L clenbuterol, approx. 56 μg/L stanozolol and approx. 8 μg/L metandienone, with trenbolone (<limit of quantification (LOQ)) were detected. Additionally, there were positive results in urine for boldenone, clomiphene, trenbolone, metandienone, stanozolol, clenbuterol and drostanolone, along with indications of testosterone and/or testosterone prohormones having been taken. In consideration of all aspects of this case, in can be assumed that the long-term consumption of anabolic androgen steroids (AAS) caused apparently pathological changes of the heart. Over and above, the combination of anatomical (small lumed coronary artery, ventricular hypertrophy) and substance-induced risk factors led to the fatal cardiovascular failure.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anabolic-androgenic steroids; Bodybuilding; Clenbuterol; Death; Doping agents; Multi-drug abuse

Mesh:

Substances:

Year:  2019        PMID: 31499423     DOI: 10.1016/j.forsciint.2019.109925

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Anabolic steroids and extreme violence: a case of murder after chronic intake and under acute influence of metandienone and trenbolone.

Authors:  Frédéric Aknouche; Laurie Gheddar; Angeline Kernalléguen; Christophe Maruejouls; Pascal Kintz
Journal:  Int J Legal Med       Date:  2021-04-04       Impact factor: 2.686

2.  Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.

Authors:  Joseph R Patterson; Warren D Hirst; Jacob W Howe; Christopher P Russell; Allyson Cole-Strauss; Christopher J Kemp; Megan F Duffy; Jared Lamp; Andrew Umstead; Michael Kubik; Anna C Stoll; Irving E Vega; Kathy Steece-Collier; Yi Chen; Anne C Campbell; Catherine L Nezich; Kelly E Glajch; Caryl E Sortwell
Journal:  NPJ Parkinsons Dis       Date:  2022-05-24

Review 3.  Advances in the Determination of Anabolic-Androgenic Steroids: From Standard Practices to Tailor-Designed Multidisciplinary Approaches.

Authors:  Lukáš Huml; Jan Tauchen; Silvie Rimpelová; Barbora Holubová; Oldřich Lapčík; Michal Jurášek
Journal:  Sensors (Basel)       Date:  2021-12-21       Impact factor: 3.576

4.  Appearance and performance-enhancing drugs and supplements, eating disorders, and muscle dysmorphia among gender minority people.

Authors:  Jason M Nagata; F Hunter McGuire; Jason M Lavender; Tiffany A Brown; Stuart B Murray; Richard E Greene; Emilio J Compte; Annesa Flentje; Micah E Lubensky; Juno Obedin-Maliver; Mitchell R Lunn
Journal:  Int J Eat Disord       Date:  2022-03-30       Impact factor: 5.791

5.  Determination of the Metabolites and Metabolic Pathways for Three β-Receptor Agonists in Rats Based on LC-MS/MS.

Authors:  Ying Liang; Lin Wang; Ruipeng Zhang; Jiadi Pan; Wenhong Wu; Yuanyuan Huang; Zifan Zhang; Renbang Zhao
Journal:  Animals (Basel)       Date:  2022-07-23       Impact factor: 3.231

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.